This part is dedicted to marketing authorisation holders and their obligations in the field of pharmacovigilance of veterinary medicinal products. There are published information how to report adverse reactions to competent authorities and EMEA. Specific attention is focused on electronic reporting and other ways for handing over of these information, e.g. using standard templates. Also information on HMA work sharing project and European Bulletin are published in this section.
Druhý článek!!Reporting of suspicion of inadequate withdrawal period - the temaplate for general adverse reaction can be used for reporting of such suspicion. In near future specific template will be prepared.